(Q44801726)

6 December 2017

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism (English)

1 reference

6 December 2017

0 references

1 reference

1 reference

13

1 reference

6 December 2017

12

Kaj Blennow

1 reference

6 December 2017

7

Margaret Gatz

1 reference

6 December 2017

3

Juni Palmgren

1 reference

6 December 2017

5

Boo Johansson

1 reference

6 December 2017

6

Nigel J Cairns

1 reference

6 December 2017

11

Anthony J Brookes

1 reference

6 December 2017

10

Nancy L Pedersen

1 reference

6 December 2017

1

Hagit Katzov

1 reference

6 December 2017

Katy Chalmers

2

1 reference

6 December 2017

Niels Andreasen

4

1 reference

6 December 2017

Gordon K Wilcock

8

1 reference

6 December 2017

Seth Love

9

1 reference

6 December 2017

Jonathan A Prince

14

1 reference

6 December 2017

1 April 2004

1 reference

6 December 2017

1 reference

6 December 2017

23

1 reference

6 December 2017

4

1 reference

6 December 2017

358-367

1 reference

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease

6 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

Heritability for Alzheimer's disease: the study of dementia in Swedish twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

Novel ABCA1 compound variant associated with HDL cholesterol deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Evidence for genetic linkage of Alzheimer's disease to chromosome 10q

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Of replications and refutations: the status of Alzheimer's disease genetic research

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Results of a high-resolution genome screen of 437 Alzheimer's disease families

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Worldwide prevalence and incidence of dementia

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Estimation of linkage disequilibrium in randomly mating populations

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Haplotype tagging for the identification of common disease genes

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

A full genome scan for late onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Haplotypes extending across ACE are associated with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Susceptibility locus for Alzheimer's disease on chromosome 10.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Genetic variation in a haplotype block spanningIDE influences Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

The accuracy of statistical methods for estimation of haplotype frequencies: an example from the CD4 locus

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20012

7 January 2021

Identifiers

DOI

10.1002/HUMU.20012

1 reference

6 December 2017

1 reference